43 related articles for article (PubMed ID: 38716480)
1. Impact of Neoadjuvant Chemotherapy (NAC) on Biomarker Expression in Breast Cancer.
Lee S; Kim JY; Lee SJ; Hwang CS; Lee HJ; Kim KB; Lee JH; Shin DH; Choi KU; Lee CH; Huh GY; Kim A
Medicina (Kaunas); 2024 Apr; 60(5):. PubMed ID: 38792920
[No Abstract] [Full Text] [Related]
2. A nomogram for predicting pathologic node negativity after neoadjuvant chemotherapy in breast cancer patients: a nationwide, multicenter retrospective cohort study (CSBrS-012).
Maimaitiaili A; Li Y; Chai N; Liu Z; Ling R; Zhao Y; Yang H; Liu Y; Liu K; Zhang J; Mao D; Yu Z; Liu Y; Fu P; Wang J; Jiang H; Zhao Z; Tian X; Cao Z; Wu K; Song A; Jin F; Wu P; He J; Fan Z; Zhang H
Front Oncol; 2024; 14():1326385. PubMed ID: 38800388
[TBL] [Abstract][Full Text] [Related]
3. Impact of Presenting Stage on Overall Survival in Patients Treated with Neoadjuvant Chemotherapy for Triple Negative Breast Cancer.
Carroll JF; Hoskin TL; Leon-Ferre RA; Boughey JC
Ann Surg Oncol; 2024 Jun; ():. PubMed ID: 38872043
[TBL] [Abstract][Full Text] [Related]
4. "Percentage" and "size" of residual viable tumor in lymph node, the performance in estimating pathologic response of lymph node in non-small cell lung cancer treated with neoadjuvant chemoimmunotherapy.
Sun W; Qu L; Wu J; Liu X; Wang C; Jiang Y; Liu Y; Chen M; Wang X; Lin D
Hum Pathol; 2024 May; 149():1-9. PubMed ID: 38782102
[TBL] [Abstract][Full Text] [Related]
5. Breast Cancer Presenting With Intravascular Tumor Emboli in Axillary Soft Tissue: Recurrence Risk and Radiation Therapy Outcomes.
Sarkar RR; Lavery JA; Zhang Z; Mueller BA; Zinovoy M; Cuaron JJ; McCormick B; Khan AJ; Powell SN; Wen HY; Braunstein LZ
Adv Radiat Oncol; 2024 Jul; 9(7):101508. PubMed ID: 38799109
[TBL] [Abstract][Full Text] [Related]
6. Role of oedema and shrinkage patterns for prediction of response to neoadjuvant chemotherapy and survival outcomes in luminal breast cancer.
Sun S; Zhou J; Bai Y; Gao W; Lin L; Jiang T; You C; Gu Y
Clin Radiol; 2024 May; ():. PubMed ID: 38830784
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of pathological nodal burden after neoadjuvant chemotherapy in initially cN0-1 breast cancer patients: a dual-center, 10-year survival analysis.
Maimaitiaili A; Fan Z; Zhang J; Wang Y; Shi B; Zheng J; Li G; Zhao Y; Pu S; He J; Qu F; Zhang H
Ther Adv Med Oncol; 2024; 16():17588359241248318. PubMed ID: 38716480
[TBL] [Abstract][Full Text] [Related]
8. Sentinel Lymph Node Biopsy vs No Axillary Surgery in Patients With Small Breast Cancer and Negative Results on Ultrasonography of Axillary Lymph Nodes: The SOUND Randomized Clinical Trial.
Gentilini OD; Botteri E; Sangalli C; Galimberti V; Porpiglia M; Agresti R; Luini A; Viale G; Cassano E; Peradze N; Toesca A; Massari G; Sacchini V; Munzone E; Leonardi MC; Cattadori F; Di Micco R; Esposito E; Sgarella A; Cattaneo S; Busani M; Dessena M; Bianchi A; Cretella E; Ripoll Orts F; Mueller M; Tinterri C; Chahuan Manzur BJ; Benedetto C; Veronesi P;
JAMA Oncol; 2023 Nov; 9(11):1557-1564. PubMed ID: 37733364
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Role of Pathological Complete Response in Early Stage Epithelial Solid Tumors.
Saltalamacchia G; Bernardo A; Quaquarini E
Cancer Control; 2023; 30():10732748231161466. PubMed ID: 37073789
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcomes of dual vs single HER2-directed neoadjuvant therapy in NSABP B-41.
Rastogi P; Tang G; Hassan S; Geyer CE; Azar CA; Magrinat GC; Suga JM; Bear HD; Baez-Diaz L; Sarwar S; Boileau JF; Brufsky AM; Shibata HR; Bandos H; Paik S; Yothers G; Swain SM; Mamounas EP; Wolmark N
Breast Cancer Res Treat; 2023 Jun; 199(2):243-252. PubMed ID: 36944848
[TBL] [Abstract][Full Text] [Related]
11. Axillary lymph node dissection: Dead or still alive?
Beck AC; Morrow M
Breast; 2023 Jun; 69():469-475. PubMed ID: 36702672
[TBL] [Abstract][Full Text] [Related]
12. Omission of axillary sentinel lymph node biopsy in early invasive breast cancer.
Reimer T
Breast; 2023 Feb; 67():124-128. PubMed ID: 36658052
[TBL] [Abstract][Full Text] [Related]
13. Axilla lymph node dissection can be safely omitted in patients with 1-2 positive sentinel nodes receiving mastectomy: a large multi-institutional study and a systemic meta-analysis.
Gao W; Lu S; Zeng Y; Chen X; Shen K
Breast Cancer Res Treat; 2022 Nov; 196(1):129-141. PubMed ID: 36076127
[TBL] [Abstract][Full Text] [Related]
14. Is the Choosing Wisely Recommendation for Omission of Sentinel Lymph Node Biopsy Applicable for Invasive Lobular Carcinoma?
Carleton N; Oesterreich S; Marroquin OC; Diego EJ; Tseng GC; Lee AV; McAuliffe PF
Ann Surg Oncol; 2022 Sep; 29(9):5379-5382. PubMed ID: 35697956
[No Abstract] [Full Text] [Related]
15. Relationship Between Breast and Axillary Pathologic Complete Response According to Clinical Nodal Stage: A Nationwide Study From Korean Breast Cancer Society.
Ryu JM; Choi HJ; Park EH; Kim JY; Lee YJ; Park S; Lee J; Park HK; Nam SJ; Kim SW; Lee JH; Lee JE;
J Breast Cancer; 2022 Apr; 25(2):94-105. PubMed ID: 35506578
[TBL] [Abstract][Full Text] [Related]
16. Pathological Response in the Breast and Axillary Lymph Nodes after Neoadjuvant Systemic Treatment in Patients with Initially Node-Positive Breast Cancer Correlates with Disease Free Survival: An Exploratory Analysis of the GeparOcto Trial.
Gerber B; Schneeweiss A; Möbus V; Golatta M; Tesch H; Krug D; Hanusch C; Denkert C; Lübbe K; Heil J; Huober J; Ataseven B; Klare P; Hahn M; Untch M; Kast K; Jackisch C; Thomalla J; Seither F; Blohmer JU; Rhiem K; Fasching PA; Nekljudova V; Loibl S; Kühn T
Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158789
[TBL] [Abstract][Full Text] [Related]
17. De-Escalating Axillary Surgery in Node-Positive Breast Cancer Treated with Neoadjuvant Systemic Therapy.
de Wild SR; Simons JM; Vrancken Peeters MTFD; Smidt ML; Koppert LB
Breast Care (Basel); 2021 Dec; 16(6):584-589. PubMed ID: 35087361
[TBL] [Abstract][Full Text] [Related]
18. De-escalating axillary surgery in early-stage breast cancer.
Hersh EH; King TA
Breast; 2022 Mar; 62 Suppl 1(Suppl 1):S43-S49. PubMed ID: 34949533
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
